Age- and sex-specific upper reference limits for cardiac biomarkers in Chinese children and adolescents: a

Kainan Dong1,2, Jinfang Xing1,2, Yanpeng Dai1,2

  • 1Department of Laboratory Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Scientific Reports
|November 16, 2024
PubMed

Insights

This study establishes crucial upper reference limits for pediatric cardiac biomarkers, including high-sensitivity cardiac troponin T (hs-cTnT), creatine kinase-MB (CK-MB) mass, and N-terminal pro-B-type natriuretic peptide (NT-proBNP). These findings aid in diagnosing cardiovascular diseases in children.

Area of Science:

  • Pediatric Cardiology
  • Clinical Biochemistry
  • Biomarker Research

Background:

  • Cardiac biomarkers are vital for diagnosing myocardial injury in children, but established upper reference limits are lacking.
  • Accurate reference limits are essential for effective disease diagnosis and health assessment in pediatric populations.
  • Previous studies have not comprehensively defined pediatric reference limits for key cardiac biomarkers.

Purpose of the Study:

  • To establish age- and gender-specific upper reference limits for hs-cTnT, CK-MB mass, and NT-proBNP in healthy children and adolescents.
  • To provide a foundational dataset for the accurate interpretation of cardiac biomarker levels in pediatric cardiovascular disease screening and diagnosis.
  • To address the critical knowledge gap regarding normal pediatric ranges for these essential cardiac markers.

Main Methods:

  • Prospective collection of 1,797 serum samples from healthy individuals aged 0-18 years.
  • Analysis of hs-cTnT, CK-MB mass, and NT-proBNP concentrations using Roche cobas e411 analyzer.
  • Calculation of upper reference limits and 90% confidence intervals following Clinical and Laboratory Standards Institute C28-A3 guidelines.

Main Results:

  • Established age-specific upper reference limits for hs-cTnT, CK-MB mass, and NT-proBNP in healthy children (0-18 years).
  • Observed higher biomarker levels in neonates, with gradual declines in concentration with increasing age, particularly within the first year.
  • Identified gender-specific differences in hs-cTnT and CK-MB mass concentrations in older children and adolescents (10-18 years), with higher levels in boys.

Conclusions:

  • Successfully established the first comprehensive upper reference limits for hs-cTnT, CK-MB mass, and NT-proBNP in a healthy Chinese pediatric cohort.
  • The findings provide essential age- and gender-specific reference ranges crucial for the accurate diagnosis and management of pediatric cardiovascular conditions.
  • These established limits will significantly support medical institutions in the preliminary screening, diagnosis, and treatment of pediatric cardiovascular diseases.